Publication | Closed Access

MRI of the joint and evaluation of the granulocyte–macrophage colony-stimulating factor–CCL17 axis in patients with rheumatoid arthritis receiving otilimab: a phase 2a randomised mechanistic study

InflammationRheumatologyRheumatoid DisorderAutoimmune DiseaseGranulocyteRheumatic DiseasesImmunologyAutoimmunityInflammatory Rheumatic DiseaseMechanistic StudyPhase 2AMedicineInflammatory DiseaseOrthopaedic SurgeryInflammatory ArthritisRheumatoid Arthritis